Physician profile
Melissa C Verde
NPI 1730135104
$257,309.38
in general payments reported to CMS, 2019-2025
23 companies · $878 in 2025
The $878 reported for 2025 was more than what 86% of Primary Podiatric Medicine providers received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $280 · 2020: $236 · 2021: $225 · 2022: $3,996 · 2023: $344 · 2024: $251K · 2025: $878.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $251K · Food and Beverage: $1,272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $251,300.00 |
| Food and Beverage | $1,272.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $251,435.06 | 2023-2024 | |
| Triad Life Sciences INC. | $3,808.01 | 2022 | |
| Smith+Nephew, INC. | $559.18 | 2019-2025 | Panta 2, Maverick, Stravix Pl |
| Integra Lifesciences Corporation | $306.23 | 2019-2020 | |
| Stryker Corporation | $272.63 | 2024-2025 | Actishield, Phalinx, Asnis |
| Paratek Pharmaceuticals, INC. | $142.37 | 2024-2025 | Nuzyra |
| Abbott Laboratories | $137.94 | 2023 | Proclaim |
| In2bones USA, LLC | $120.00 | 2019 | |
| Treace Medical Concepts, INC. | $100.00 | 2025 | |
| Grt US Holding, INC. | $99.26 | 2022 | |
| Horizon Therapeutics Plc | $89.66 | 2021 | |
| Organogenesis INC. | $37.97 | 2025 | Cygnus Dual, Novachor |
| Amniox Medical, INC. | $31.90 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $25.07 | 2021-2025 | Jublia |
| Musculoskeletal Transplant Foundation INC. | $22.79 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $17.50 | 2025 | Senza |
| Medtronic, INC. | $17.09 | 2025 | Intellis Adaptivestim |
| Atland Pharmaceuticals, LLC | $16.84 | 2025 | Orphenadrine Citrate, Aspirin and Caffeine, Tolmetin Sodium |
| Mimedx Group, INC. | $16.28 | 2025 | |
| Sanara Medtech INC. | $15.95 | 2025 | Celleraterx |
| Lifenet Health | $14.87 | 2025 | Theragenesis Wound Matrix |
| Zyla Life Sciences, INC. | $14.53 | 2020 | |
| Orthofix Medical, INC. | $8.25 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Verde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.